Position paper of the Spanish Society of Radiotherapeutic Oncology (SEOR) and its genitourinary tumors group (URONCOR) on the prescription of parp inhibitors in advanced prostate cancer

Diezhandino, P.; Couñago, F.; Ocanto, A.; Gómez de Iturriaga, A.; Conde, A.; Maldonado, X.; Serrano, J.; López-Campos, F.

doi:10.1016/j.acuroe.2026.501991

Actas Urológicas Españolas (English Edition)

ISSN: 2173-5786

Actas Urológicas Españolas is an international journal dedicated to urological diseases and renal transplant. It has been the official publication of the Spanish Urology Association since 1977 and of the American Urology Confederation since 2008. Its articles cover all aspects related to urology.
Actas Urológicas Españolas, governed by the peer review system (double blinded), is published online in Spanish and English. Consequently, manuscripts may be sent in Spanish or English and bidirectional free cost translation will be provided. It has high visibility and accessibility and is found in the most important data bases, Medline/Pubmed, Emabase, JCR, Ïndice Médico Español, Índice bibliográfico Español en Ciencias de la Salud (IBECS), Cuiden, Dialnet, Hinari, Scopus, Google Scholar.

See more Open Access Option

Indexed in:

Medline

RSS

Contact

Tienda

Alert

Newsletter

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

Impact factor 2025

1.7

Citescore

CiteScore measures average citations received per document published.

Citescore 2024

2.2

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2024

0.440

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2024

0.628

View more metrics

Journal Information

Previous article | Next article

Vol. 50. Issue 6.

(July - August 2026)

Lee este artículo en Español

Cite

Diezhandino P, Couñago F, Ocanto A, Gómez de Iturriaga A, Conde A, Maldonado X, et al. Position paper of the Spanish Society of Radiotherapeutic Oncology (SEOR) and its genitourinary tumors group (URONCOR) on the prescription of parp inhibitors in advanced prostate cancer. Actas Urol Esp. 2026;50:

Copy

Download PDF

Position paper of the Spanish Society of Radiotherapeutic Oncology (SEOR) and its genitourinary tumors group (URONCOR) on the prescription of parp inhibitors in advanced prostate cancer

Documento de posicionamiento de la Sociedad Española de Oncología Radioterápica (SEOR) y su grupo de tumores genitourinarios (URONCOR) sobre la prescripción de inhibidores de parp en cáncer de próstata avanzado

Visits

365

Download PDF

P. Diezhandinoa, F. Couñagob,c,d, A. Ocantob,c,

Corresponding author

abrahams.ocanto@genesiscare.es

Corresponding author.

, A. Gómez de Iturriagae, A. Condef, X. Maldonadog, J. Serranoh, F. López-Camposi

a Servicio de Oncología Radioterápica, Hospital Clínico Universitario de Valladolid, Valladolid, Spain

b Servicio de Oncología Radioterápica, Hospital Universitario San Francisco de Asís, GenesisCare, Madrid, Spain

c Servicio de Oncología Radioterápica, Hospital Universitario Vithas La Milagrosa, GenesisCare, Madrid, Spain

d Facultad de Medicina, Salud y Deporte, Universidad Europea de Madrid, Villaviciosa de Odón, Madrid, Spain

e Hospital Universitario de Cruces, Instituto de Investigación Sanitaria de Bizkaia, Universidad del País Vasco (UPV/EHU), Bizkaia, Spain

f Servicio de Oncología Radioterápica, Hospital Universitario y Politécnico La Fe, Valencia, Spain

g Servicio de Radioterapia, Hospital Universitario Vall d'Hebron, Barcelona, Spain

h Servicio de Oncología Radioterápica, Clínica Universidad de Navarra, Madrid, Spain

i Servicio de Oncología Radioterápica, Hospital Universitario Ramón y Cajal, Madrid, Spain

This item has received

365 Visits

Article information

Full Text

Bibliography

Download PDF

Statistics

Article

These are the options to access the full texts of the publication Actas Urológicas Españolas (English Edition)

Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”

Purchase

Purchase article

Purchasing article the PDF version will be downloaded

Purchase now

Contact

Phone for subscriptions and reporting of errors

From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.

Calls from Spain

932 415 960

Calls from outside Spain

+34 932 415 960

E-mail

atencionalcliente@elsevier.com

Position paper of the Spanish Society of Radiotherapeutic Oncology (SEOR) and its genitourinary tumors group (URONCOR) on the prescription of parp inhibitors in advanced prostate cancer

Article

Subscribe to our newsletter